►个人简介吕慧侠：女，1977年出生，博士，药剂学专业副教授，主要从事口服制剂、靶向给药系统和新型功能材料的研究，注重药剂学科研和制剂产业化的有机结合。近年来主持或承担省部级以上科研项目10项、产业化课题3项；发表论文30多篇，参编药剂学相关著作5部；发明专利授权5项，获得中国药学会和中华中医药学会科技进步三等奖各1项。►研究方向靶向给药载体、口服制剂、透皮给药系统及功能高分子材料。►联系方式lvhuixia@163.com。►近年来主持和承担的主要科研项目1、仿生型多糖衍生物口服递送胰岛素及其机制的研究(国科金30901867)2、肿瘤细胞选择性穿膜肽及其复合纳米载体技术的研究(国科金30973649)3、基于肠道受体吸收的水飞蓟素口服纳米载体研究（国科金81274108）4、一种脑肿瘤分级靶向纳米载体的研究（博士点基金20110096110005）5、新型逆转肿瘤多药耐药脂质体的研究（博士点基金20090096110002）6、胰岛素与穿膜肽自组装口服给药系统的研究（中央高校基金JKQ2011016）7、虫草多糖胶囊新药临床前研究（十一五重大专项）8、新剂型与新释药系统技术平台（十一五重大专项）►代表性文章1、Tianyue Jiang, Zhenhai Zhang, Yinlong Zhang, Huixia Lv*, Jianping Zhou*, Caocao Li, Lulu Hou, Qiang Zhang, Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery, Biomaterials, 2012.2、Zhen-Hai Zhang, Sarra Abbad, Rui-Rui Pan, Ayman Y. Waddad, Lu-Lu Hou, Hui-Xia Lv*, Jian-Ping Zhou*, N-Octyl-N-Arginine Chitosan Micelles as an Oral Delivery System of Insulin, Journal of Biomedical Nanotechnology, 2013.3、Were L.L.Munyendo, Zhenhai Zhang, Sarra Abbad, Ayman Y. waddad, Hui-Xia Lv*, Jian-Ping Zhou*. Micelles of TPGS Modified Apigenin Phospholipid Complex for Oral Administration: Preparation, In Vitro and In Vivo Evaluation. Journal of Biomedical Nanotechnology, 2013.4、Ayman Y. Waddad, Sarra Abbad, Fan Yu, Were L.L. Munyendo, Wang Jing, Huixia Lv*, Jianping Zhou*, Formulation, characterization and pharmacokinetics of Morin hydrate niosomes prepared from various non-ionic surfactants. International Journal of Pharmaceutics, 2013.5、Zhen-Hai Zhang, Xiao-Pan Wang, Waddad Y. Ayman, Were L. L. Munyendo, Hui-Xia Lv*, Jian-Ping Zhou*, Studies on lactoferrin nanoparticles of gambogic acid for oral delivery, Drug Delivery, 2013.